NIAID Banner Logo Image

Other Viruses Citation List:

February 17 - March 1, 2012

Hepatitis B virus

1. Inhibition of Hepatitis B Virus Replication by Phospholipid scramblase 1 in Vitro and in Vivo. Yang, J., X. Zhu, J. Liu, X. Ding, M. Han, W. Hu, X. Wang, Z. Zhou, and S. Wang, Antiviral Research, 2012. [Epub ahead of print]; PMID[22342889].

[PubMed]. OV_0217-030112.

Hepatitis C Virus

2. Optimization of Benzoisothiazole dioxide Inhibitory Activity of the NS5B polymerase of HCV Genotype 4 Using Ligand-steered Homological Modeling, Reaction-driven Scaffold-hopping and Enovo Workflow. Mahmoud, A.H., K.A. Mohamed Abouzid, D.A. El Ella, and M.A. Hamid Ismail, Bioinformation, 2011. 7(7): p. 328-333; PMID[22355232].

[PubMed]. OV_0217-030112.

3. Cellular Growth Kinetics Distinguish a Cyclophilin Inhibitor from an HSP90 Inhibitor as a Selective Inhibitor of Hepatitis C Virus. Beran, R.K., R. Sharma, A.C. Corsa, Y. Tian, J. Golde, G. Lundgaard, W.E.t. Delaney, W. Zhong, and A.E. Greenstein, PloS One, 2012. 7(2): p. e30286; PMID[22347373].

[PubMed]. OV_0217-030112.

4. Novel Hepatitis C Virus Replicon Inhibitors: Synthesis and Structure-Activity Relationships of Fused Pyrimidine Derivatives. Chris Krueger, A., D.L. Madigan, D.W. Beno, D.A. Betebenner, R. Carrick, B.E. Green, W. He, D. Liu, C.J. Maring, K.F. McDaniel, H. Mo, A. Molla, C.E. Motter, T.J. Pilot-Matias, M.D. Tufano, and D.J. Kempf, Bioorganic & Medicinal Chemistry Letters, 2012. [Epub ahead of print]; PMID[22342631].

[PubMed]. OV_0217-030112.

HSV-1

5. Synthesis and anti-HSV-1 Evaluation of New 3H-Benzo[b]pyrazolo[3,4-h]-1,6-naphthyridines and 3H-Pyrido[2,3-b]pyrazolo[3,4-h]-1,6-naphthyridines. Bernardino, A.M., A.R. Azevedo, L.C. Pinheiro, J.C. Borges, I.C. Paixao, M. Mesquita, T.M. Souza, and M.S. Dos Santos, Organic and Medicinal Chemistry Letters, 2012. 2(1): p. 3; PMID[22373524].

[PubMed]. OV_0217-030112.

Citations from the ISI Web of Knowledge Listings for O.V.

6. Novel HCV NS5B polymerase Inhibitors: Discovery of Indole C2 acyl sulfonamides. Anilkumar, G.N., O. Selyutin, S.B. Rosenblum, Q.B. Zeng, Y.H. Jiang, T.Y. Chan, H.Y. Pu, L. Wang, F. Bennett, K.X. Chen, C.A. Lesburg, J. Duca, S. Gavalas, Y.H. Huang, P. Pinto, M. Sannigrahi, F. Velazquez, S. Venkatraman, B. Vibulbhan, S. Agrawal, E. Ferrari, C.K. Jiang, H.C. Huang, N.Y. Shih, F.G. Njoroge, and J.A. Kozlowski, Bioorganic & Medicinal Chemistry Letters, 2012. 22(1): p. 713-717; PMID[WOS:000298636700140].

[WOS]. OV_0217-030112.

7. Discovery of BILB 1941, a Non-nucleoside polymerase Inhibitor for the Treatment of Hepatitis C Virus Infection. Brochu, C., Abstracts of Papers of the American Chemical Society, 2011. 242; PMID[WOS:000299378305455].

[WOS]. OV_0217-030112.

8. Structure-Activity Relationship (SAR) Development and Discovery of Potent Indole-based Inhibitors of the Hepatitis C Virus (HCV) NS5B Polymerase. Chen, K.X., B. Vibulbhan, W.Y. Yang, M. Sannigrahi, F. Velazquez, T.Y. Chan, S. Venkatraman, G.N. Anilkumar, Q.B. Zeng, F. Bennet, Y.H. Jiang, C.A. Lesburg, J. Duca, P. Pinto, S. Gayalas, Y.H. Huang, W.L. Wu, O. Selyutin, S. Agrawal, B. Feld, H.C. Huang, C. Li, K.C. Cheng, N.Y. Shih, J.A. Kozlowski, S.B. Rosenblum, and F.G. Njoroge, Journal of Medicinal Chemistry, 2012. 55(2): p. 754-765; PMID[WOS:000299453300019].

[WOS]. OV_0217-030112.

9. Towards a Stable Noeuromycin Analog with a D-Manno Configuration: Synthesis and Glycosidase Inhibition of D-Manno-like Tri- and Tetrahydroxylated azepanes. Deschamp, J., M. Mondon, S. Nakagawa, A. Kato, D.S. Alonzi, T.D. Butters, Y.M. Zhang, M. Sollogoub, and Y. Bleriot, Bioorganic & Medicinal Chemistry, 2012. 20(2): p. 641-649; PMID[WOS:000299496100013].

[WOS]. OV_0217-030112.

10. Antiviral Activity of Conyza canadensis (L.) Cronquist Extracts Grown in Tunisia. Edziri, H.L., G. Laurent, A. Mahjoub, and M. Mastouri, African Journal of Biotechnology, 2011. 10(45): p. 9097-9100; PMID[WOS:000299734600014].

[WOS]. OV_0217-030112.

11. Pyridobenzothiazole Derivatives as New Chemotype Targeting the Hat NS5B polymerase. Manfroni, G., F. Meschini, M.L. Barreca, P. Leyssen, A. Samuele, N. Iraci, S. Sabatini, S. Massari, G. Maga, J. Neyts, and V. Cecchetti, Bioorganic & Medicinal Chemistry, 2012. 20(2): p. 866-876; PMID[WOS:000299496100038].

[WOS]. OV_0217-030112.

12. Model for Inhibition of HCV NS5b polymerase by Nucleoside Analogs. Perry, J.K., Abstracts of Papers of the American Chemical Society, 2011. 242; PMID[WOS:000299378302136].

[WOS]. OV_0217-030112.

13. Discovery of the Novel HCV NS3 protease Inhibitor, GS-9451. Pyun, H., C. Sheng, T. Appleby, O. Barauskas, T. Butler, R. Cai, X.W. Chen, A. Cho, M. Clarke, A. Corsa, E. Doerffler, M. Hung, M.Z. Ji, J. Link, X.H. Liu, R. Pakdaman, M. Robinson, B. Schultz, C. Tay, Q.Y. Wu, J. Xu, C. Yang, H.L. Yang, W. Delaney, and C. Kim, Abstracts of Papers of the American Chemical Society, 2011. 242; PMID[WOS:000299378304490].

[WOS]. OV_0217-030112.

14. Structure-based Drug Design and the Evaluation of Irreversible HCV-protease Inhibitors. Qiao, L.X., D.Q. Niu, Z.D. Zhu, M. Labenski, M. Hagel, T. St Martin, M. Sheet, H. Bernard, M. Nacht, W. Westlin, R. Petter, and J. Singh, Abstracts of Papers of the American Chemical Society, 2011. 242; PMID[WOS:000299378304405].

[WOS]. OV_0217-030112.

15. Inhibition of Hepatitis C Virus Replication by Single and Dual Small Interfering RNA Using an HCV-infected Cell Model.. Xing, X.K., S.J. Li, J.L. He, and Z. Chen, Biotechnology Letters, 2012. 34(2): p. 295-301; PMID[WOS:000299510200016].

[WOS]. OV_0217-030112.

16. Diastereoselective Synthesis of a Purine phosphoramidate Prodrug Inhibitor of HCV NS5B polymerase. Zhang, H.R., P.G. Reddy, B.S. Ross, S. Rachakonda, and M.J. Sofia, Abstracts of Papers of the American Chemical Society, 2011. 242; PMID[WOS:000299378305580].

[WOS]. OV_0217-030112.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022